Sarepta Therapeutics, Inc.
NasdaqGS:SRPT
$ 116.96
+ $1.34 (1.16%)
$ 116.96
+ $1.34 (1.16%)
End-of-day quote: 04/22/2024

SRPT - Sarepta Therapeutics Stock Prediction 2025 - 2030

20 years of reliable Sarepta Therapeutics stock forecast. The Wall Street analysts predict Outperform for SRPT. See at a glance whether NasdaqGS:SRPT will rise in the future.

$0.00
Forecast 2023
$140.05
Forecast 2025
$238.02
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$140.05
Forecast 2030
$238.02
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.95
Price-to-book Ratio
12.75
Market Cap
10.85B
TEV
12.90 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$158.66

Sarepta Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Sarepta Therapeutics Stock Forecast 2023

$165.50

In the last five quarters, Sarepta Therapeutics’s Price Target has risen from $129.07 to $158.66 - a 22.93% increase. Fourteen analysts predict that Sarepta Therapeutics’s share price will increase in the coming year, reaching $165.50. This would represent an increase of 4.31%.

41.5%
41.5
Last update: 04/23/2024

Highest Price Target $224.00

Average Price Target $165.50

Lowest Price Target $128.00

Sarepta Therapeutics Stock Predictions 2025

Stock Forecast for the Price of an Sarepta Therapeutics Share in Jan 2025.

In January 2025, analysts believe the stock price will be $127.13. An increase of 8.7% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Feb 2025.

In February 2025, analysts believe the stock price will be $128.31. An increase of 9.7% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Mar 2025.

In March 2025, analysts believe the stock price will be $129.48. An increase of 10.71% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Apr 2025.

In April 2025, analysts believe the stock price will be $130.66. An increase of 11.71% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in May 2025.

In May 2025, analysts believe the stock price will be $131.83. An increase of 12.71% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Jun 2025.

In June 2025, analysts believe the stock price will be $133.01. An increase of 13.72% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Jul 2025.

In July 2025, analysts believe the stock price will be $134.18. An increase of 14.72% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Aug 2025.

In August 2025, analysts believe the stock price will be $135.35. An increase of 15.73% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Sep 2025.

In September 2025, analysts believe the stock price will be $136.53. An increase of 16.73% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Oct 2025.

In October 2025, analysts believe the stock price will be $137.70. An increase of 17.74% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Nov 2025.

In November 2025, analysts believe the stock price will be $138.88. An increase of 18.74% compared to the previous month's estimate.

Stock Forecast for the Price of an Sarepta Therapeutics Share in Dec 2025.

In December 2025, analysts believe the stock price will be $140.05. An increase of 19.74% compared to the previous month's estimate.

Sarepta Therapeutics Stock Prediction 2030

Stock Prediction for the Price of One Sarepta Therapeutics Share in Jan 2030.

In Jan 2030 analysts predict a share price of $216.07. An increase of 84.73% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Feb 2030.

In Feb 2030 analysts predict a share price of $218.06. An increase of 86.44% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Mar 2030.

In Mar 2030 analysts predict a share price of $220.06. An increase of 88.15% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Apr 2030.

In Apr 2030 analysts predict a share price of $222.05. An increase of 89.86% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in May 2030.

In May 2030 analysts predict a share price of $224.05. An increase of 91.56% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Jun 2030.

In Jun 2030 analysts predict a share price of $226.05. An increase of 93.27% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Jul 2030.

In Jul 2030 analysts predict a share price of $228.04. An increase of 94.98% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Aug 2030.

In Aug 2030 analysts predict a share price of $230.04. An increase of 96.68% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Sep 2030.

In Sep 2030 analysts predict a share price of $232.04. An increase of 98.39% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Oct 2030.

In Oct 2030 analysts predict a share price of $234.03. An increase of 100.1% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Nov 2030.

In Nov 2030 analysts predict a share price of $236.03. An increase of 101.8% compared to today's share price.

Stock Prediction for the Price of One Sarepta Therapeutics Share in Dec 2030.

In Dec 2030 analysts predict a share price of $238.02. An increase of 103.51% compared to today's share price.

P/E
0.00
Beta
0.95
Price-to-book Ratio
12.75
Market Cap
10.85B
TEV
12.90 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$158.66

Sarepta Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Sarepta Therapeutics, Inc.?

The following analysts have recently covered Sarepta Therapeutics:

Baird
Barclays
BofA Global Research
Cantor Fitzgerald & Co.
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Marktfeld
Mizuho Securities USA LLC
Morgan Stanley
Needham & Company
Oppenheimer & Co. Inc.
Raymond James & Associates
RBC Capital Markets
UBS Investment Bank
William Blair & Company L.L.C.
Citigroup Inc
Citigroup Inc. Research
Equisights
Leerink Partners LLC
TD Cowen
Wedbush Securities Inc.
BMO Capital Markets Equity Research
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Sarepta Therapeutics, Inc.?

The following sell-side analysts have recently covered Sarepta Therapeutics:

Skorney, Brian Peter
Wang, Huidong
Ahmad, Tazeen
Brill Bongero, Danielle Catherine
Baral, Ritu Subhalaksmi
Richter, Salveen Jaswal
Chattopadhyay, Debjit D.
Rama, Anupam
Paraskevopoulos, Michail
Ear, Uy Sieng
Blum, Gil Joseph
Singh, Hartaj
Davis, Luke
Schwartz, Joseph Patrick
Bristow, Colin Nigel
Lugo, Timothy Francis
Kluska, Kristen Brianne
Hoang, David Timothy
Talsania, Parth
Clark-Gartner, Gavin
Ulz, Michael Eric
Argyrides, Andreas
Biliouris, Konstantinos
(This information refers to the last 90 days.)